TEM Tempus AI, Inc.

매출 +50% 고성장, 영업이익률 개선(+4.9%p). 다만 공매도 잔고 25%. 11/2 실적 발표 예정.

종가$67.76
시가총액$117억
업종헬스케어
다음 실적 발표2026-11-02
매출 성장(최근 4분기)+50%
영업이익률-20%
애널리스트 순상향률+7.1%
목표가 상승여력+11%
공매도 거래 비중46%
유명 투자자 보유1곳
1년 수익률-27%

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostic

2026-10-21 기준 · 출처: SEC EDGAR, FINRA, yfinance · 정보 제공용이며 투자 권유가 아닙니다

같은 업종 종목